These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38618883)

  • 1. A 14-year-old girl with premature ovarian insufficiency but with a positive pregnancy test.
    Touwslager RNH; Zwaan CM; Bakker B; Lentjes EGWM; Looijenga LHJ; van Santen HM
    J Pediatr Endocrinol Metab; 2024 May; 37(5):482-485. PubMed ID: 38618883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone sulfate levels reflect endogenous luteinizing hormone production and response to human chorionic gonadotropin challenge in older female macaque (Macaca fascicularis).
    Moran FM; Chen J; Gee NA; Lohstroh PN; Lasley BL
    Menopause; 2013 Mar; 20(3):329-35. PubMed ID: 23435031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
    Papapetrou PD; Anagnostopoulos NI
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
    Mann RJ; Keri RA; Nilson JH
    Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.
    Takizawa A; Kawai K; Kawahara T; Kojima T; Maruyama S; Shinohara N; Akamatsu S; Kamba T; Nakamura T; Ukimura O; Jikuya R; Kishida T; Kakimoto K; Nishimura K; Harabayashi T; Nagamori S; Yamashita S; Arai Y; Sawada Y; Sekido N; Kinoshita H; Matsuda T; Nakagawa T; Homma Y; Nishiyama H
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):109-115. PubMed ID: 28905168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of the gonadotrophin response to LH-RH and oestrogen administration in patients after molar abortion.
    Miyake A; Aono T; Tanizawa O; Kurachi H; Kurachi K
    Acta Endocrinol (Copenh); 1979 May; 91(1):30-5. PubMed ID: 222100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: an unusual case of adrenal neuroblastoma in pregnancy.
    Refaat MM; Idriss SZ; Blaszkowsky LS
    Oncologist; 2008 Feb; 13(2):152-6. PubMed ID: 18305060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
    Jeppsson S; Rannevik G; Thorell JI
    Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation.
    Wei M; Zhang XM; Gu FL; Lv F; Ji YR; Liu KF; She H; Hu R
    Clin Exp Obstet Gynecol; 2015; 42(3):361-6. PubMed ID: 26152012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
    Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
    Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous Recovery of Ovarian Function in an Adolescent with Galactosemia and Apparent Premature Ovarian Insufficiency.
    Davies P; Connor E; MacKenzie J; Jamieson MA
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):e101-3. PubMed ID: 26024933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
    Escudero EL; Boerrigter PJ; Bennink HJ; Epifanio R; Horcajadas JA; Olivennes F; Pellicer A; Simón C
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2081-8. PubMed ID: 15483085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary as a Source of HCG: Residual Levels After Bilateral Testicular Tumor Removal.
    Santen R; Hasan F; Thoren K; Farooki A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619841414. PubMed ID: 31010310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study.
    Flatt SB; Baillargeon A; McClintock C; Pudwell J; Velez MP
    Reprod Health; 2023 Jan; 20(1):4. PubMed ID: 36593491
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.